COMPARISON OF THE DIAGNOSTIC VALUE OF MRI AND ULTRASOUND IN THE STUDIED PATIENTS AND DETERMINATION OF PROGNOSTIC FACTORS OF ENDOMETRIAL CANCER

Abstract

Endometrial cancer (EM) is the most common malignant tumor in women, most often of reproductive age. EC are detected, according to various sources, in 25 - 50% of women under the age of 50 years. We analyzed the results of examination and treatment of 98 patients. The criterion for inclusion in this study was a morphologically verified squamous EC of stages IB2, IIB and IIIB, the results showed that it is advisable to subject endometrial cancer patients with identified metastases to a special one (chemo, chemoradiotherapy followed by radical operations), as this leads to improved results (in in our study by more than 20%) and an increase in the life expectancy of these patients, also, depending on the stage, depth of tumor invasion and those treated with neoadjuvant chemotherapy and subsequent radical operations: for example, the five-year relapse-free and overall survival rates were 79.6% and 87 .5%, respectively, in patients with EC stages IB2 - IIIB, which is approximately 20% higher than similar indicators among patients who underwent only combined radiation therapy.